Kitchener, Ontario – March 3rd, 2026, Medical Innovation Xchange (MIX) is thrilled to welcome DigiBiomics as the newest affiliate company in our growing ecosystem of Canadian med‑tech innovators. DigiBiomics joins MIX at a pivotal stage in its development, bringing a forward‑looking vision for transforming respiratory care through AI‑powered diagnostics.
DigiBiomics is building LungSense, an advanced respiratory diagnostics platform designed to shift lung health from reactive treatment to proactive prevention. By analyzing cough, breath sounds, and clinical context through AI, LungSense enables earlier detection and timely intervention. With applications across long‑term care, home health, remote clinics, and telehealth, DigiBiomics is helping deliver accessible, real‑time respiratory insights to the people who need them most.
This technology represents a meaningful step toward more preventive, data‑driven respiratory care, offering scalable support for providers working to improve outcomes in high‑need populations.
By joining MIX, DigiBiomics gains access to founders and teams who understand the realities of building, validating, and scaling regulated health‑tech solutions in Canada and beyond.
“We joined MIX because of its strong commitment to connecting innovators with real‑world healthcare needs,” the DigiBiomics team shared. “The collaborative ecosystem MIX fosters is exactly what growing health‑tech companies like ours need to move from pilots to impact.”
DigiBiomics is eager to collaborate with MIX companies on clinical partnerships, scaling and deployment with long‑term care and home‑care providers, commercialization pathways, and accelerating the responsible adoption of AI in respiratory care. As they prepare for broader deployment, DigiBiomics is focused on building the partnerships and pathways needed to bring LungSense into more clinical environments.
We’re excited to support DigiBiomics as they continue advancing AI‑enabled respiratory diagnostics and scaling their platform toward meaningful clinical impact. Their mission aligns deeply with MIX’s vision. If you’d like to learn more about Digibiomics, click here. If you would like to learn more about MIX and how it works, click here.
